You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 52 No. 2, February 1995 TABLE OF CONTENTS
  Archives
  •  Online Features
  Letters to the Editor
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Survival in Amyotrophic Lateral Sclerosis

Lawrence S. Honig, MD, PhD
Department of Neurology and Neurological Sciences Stanford University Medical Center Stanford, CA 94305-5235

Arch Neurol. 1995;52(2):126.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The article by McDonald et al1 in the January issue of the ARCHIVES purports to confirm the authors' hypothesis that "psychological distress is associated with greater mortality" among a group of North American patients with amyotrophic lateral sclerosis (ALS). As the authors indicate, the proposition that psychological factors may influence the course of a variety of medical conditions of poor prognosis (eg, widely metastatic cancer) is rather controversial, with various studies reaching affirmative and negative conclusions. However, study of this theory for ALS is particularly problematic. In part, this arises from varying rates of disease progression (and, indeed, the authors' "psychologically well" group with 6 to 10 years average duration of illness by the end of the study may have more indolent disease, for which they attempted to partially control). However, a major difficulty is the use of survival as a criterion for disease progression.

Duration of survival in . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.